BRKR vs ENSG: Which Stock Is the Better Buy?
Bruker Corporation and The Ensign Group, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — BRKR vs ENSG, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Bruker Corporation (BRKR) | The Ensign Group, Inc. (ENSG) | |
|---|---|---|
| Market cap | $8.4B | $8.9B |
| Revenue (latest FY) | $3.44B | $5.06B |
| Net income (latest FY) | $-22.50M | $343.97M |
| Revenue growth (5y CAGR) | 11.6% | 16.1% |
| Net margin | -0.7% | 6.8% |
| Return on equity | -0.9% | 15.4% |
| P/E ratio | — | 24.6 |
| Dividend yield | 0.3% | 0.2% |
| Profitable years (of last 10) | 9 | 10 |
| Positive free cash flow | Yes | — |
See the full BRKR vs ENSG breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open BRKR's full financials → Open ENSG's full financials →More comparisons
Frequently asked questions
Which is bigger, BRKR or ENSG?
The Ensign Group, Inc. is larger by market capitalization — $8.9B versus $8.4B.
Which grows faster, BRKR or ENSG?
Over the last five fiscal years, The Ensign Group, Inc. grew revenue faster — 16.1%/yr versus 11.6%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.